1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL ANESTHESIA DRUG MARKET : EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360-DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. RISING NUMBER OF SURGERIES
3.1.2. EVOLUTION OF NEW SEDATIVE 7 ANESTHETIC DRUGS
3.1.3. DECREASE IN THE PRICE OF NEWLY INVENTED DRUGS
3.1.4. REDUCTION IN THE RECOVERY TIME SUBSEQUENTLY SURGERY
3.2. MARKET RESTRAINTS
3.2.1. SIDE EFFECTS OF ANESTHESIA DRUGS
3.2.2. AVAILABILITY OF SKILLED ANESTHETICS EXPERTS
3.3. MARKET OPPORTUNITIES
3.3.1. RISING PRIVATE & PUBLIC HEALTH INSURERS
3.3.2. AVAILABILITY IN GENERIC FORM & LOW COST PRODUCTS
3.4. MARKET CHALLENGES
3.4.1. IMPACT ON NARROW RANGE OF AILMENTS
4. GLOBAL ANESTHESIA DRUGMARKET BY TYPE
4.1. MARKET DEFINITION AND SCOPE
4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4. OPPORTUNITY MATRIX
4.5. MARKET SEGMENTATION
4.5.1. GLOBAL GENERAL ANESTHESIA MARKET
4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.1.3. KEY CONCLUSIONS
4.5.2. GLOBAL SPINAL ANESTHESIA MARKET
4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.2.3. KEY CONCLUSIONS
4.5.3. GLOBAL PERIPHERAL NERVE BLOCK MARKET
4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.3.3. KEY CONCLUSIONS
4.5.4. GLOBAL SADDLE BLOCK ANESTHESIA MARKET
4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.4.3. KEY CONCLUSIONS
4.5.5. GLOBAL INTERSCALENE BLOCK MARKET
4.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.5.3. KEY CONCLUSIONS
4.5.6. GLOBAL IV REGIONAL ANESTHESIA MARKET
4.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
4.5.6.3. KEY CONCLUSIONS
5. GLOBAL ANESTHESIA DRUGMARKET BY ROUTES OF ADMINISTRATION
5.1. MARKET DEFINITION AND SCOPE
5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
5.4. OPPORTUNITY MATRIX
5.5. MARKET SEGMENTATION
5.5.1. GLOBAL INJECTION MARKET
5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.1.3. KEY CONCLUSIONS
5.5.2. GLOBAL INHALATION MARKET
5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
5.5.2.3. KEY CONCLUSIONS
6. GLOBAL ANESTHESIA DRUGMARKET BY PRODUCT
6.1. MARKET DEFINITION AND SCOPE
6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.4. OPPORTUNITY MATRIX
6.5. MARKET SEGMENTATION
6.5.1. GLOBAL PROPOFOL MARKET
6.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
6.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.1.3. KEY CONCLUSIONS
6.5.2. GLOBAL SEVOFLURANE MARKET
6.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
6.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.2.3. KEY CONCLUSIONS
6.5.3. GLOBAL DESFLURANE MARKET
6.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
6.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.3.3. KEY CONCLUSIONS
6.5.4. GLOBAL REMIFENTANIL MARKET
6.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
6.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.4.3. KEY CONCLUSIONS
6.5.5. GLOBAL MIDAZOLAM MARKET
6.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
6.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.5.3. KEY CONCLUSIONS
6.5.6. GLOBAL DEXMEDETOMIDINE MARKET
6.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
6.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.6.3. KEY CONCLUSIONS
6.5.7. GLOBAL OTHERS MARKET
6.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
6.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
6.5.7.3. KEY CONCLUSIONS
7. COMPETITIVE LANDSCAPE
7.1. KEY STRATEGIES
7.1.1. LIST OF MERGERS AND ACQUISITION
7.1.2. LIST OF JOINT VENTURES
7.1.3. LIST OF PRODUCT LAUNCHES
7.1.4. LIST OF PARTNERSHIPS
8. GEOGRAPHIC ANALYSIS
8.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
8.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
8.3. OPPORTUNITY MATRIX
8.4. GLOBAL ANESTHESIA DRUGMARKET BY REGION 2015-2024
8.4.1. NORTH AMERICA
8.4.1.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
8.4.1.2. TOP COUNTRY ANALYSIS
8.4.1.2.1. U.S.
8.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.1.2.1.2. KEY CONCLUSIONS
8.4.1.2.2. CANADA
8.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.1.2.2.2. KEY CONCLUSIONS
8.4.2. EUROPE
8.4.2.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
8.4.2.2. TOP COUNTRY ANALYSIS
8.4.2.2.1. UK
8.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.2.2.1.2. KEY CONCLUSIONS
8.4.2.2.2. FRANCE
8.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.2.2.2.2. KEY CONCLUSIONS
8.4.2.2.3. GERMANY
8.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.2.2.3.2. KEY CONCLUSIONS
8.4.2.2.4. SPAIN
8.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.2.2.4.2. KEY CONCLUSIONS
8.4.2.2.5. REST OF EUROPE
8.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.2.2.5.2. KEY CONCLUSIONS
8.4.3. ASIA PACIFIC
8.4.3.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
8.4.3.2. TOP COUNTRY ANALYSIS
8.4.3.2.1. CHINA
8.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.3.2.1.2. KEY CONCLUSIONS
8.4.3.2.2. INDIA
8.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.3.2.2.2. KEY CONCLUSIONS
8.4.3.2.3. JAPAN
8.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.3.2.3.2. KEY CONCLUSIONS
8.4.3.2.4. AUSTRALIA
8.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.3.2.4.2. KEY CONCLUSIONS
8.4.3.2.5. REST OF ASIA PACIFIC
8.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.3.2.5.2. KEY CONCLUSIONS
8.4.4. ROW
8.4.4.1. INDUSTRY ANALYSIS 2015-2024 ($ MILLION)
8.4.4.2. TOP COUNTRY ANALYSIS
8.4.4.2.1. LATIN AMERICA
8.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.4.2.1.2. KEY CONCLUSIONS
8.4.4.2.2. MIDDLE EAST & AFRICA
8.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)
8.4.4.2.2.2. KEY CONCLUSIONS
9. COMPANY PROFILES
9.1. ABBOT LABORATORIES(US)
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. STRATEGIC INITIATIVES
9.1.4. SCOT ANALYSIS
9.1.5. STRATEGIC ANALYSIS
9.2. ASTRA ZENECA(UK)
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. BAXTER INTERNATIONAL INC(UK)
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVES
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. BOEHRINGER INGELHEIM(GERMANY)
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT ANALYSIS
9.4.5. STRATEGIC ANALYSIS
9.5. EISAI CO LTD(JAPAN)
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. FRESENIUS SE & CO KGAA(GERMANY)
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVES
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. HIKMA PHARMACEUTICALS PLC(UK)
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. HOSPIRA INC(US)
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. MYLAN NV(US)
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. NOVARTIS(SWITZERLAND)
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. STRATEGIC INITIATIVES
9.10.4. SCOT ANALYSIS
9.10.5. STRATEGIC ANALYSIS
9.11. PAR PHARMACEUTICALS COMPANIES INC(US)
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. PIRAMAL(INDIA)
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. STRATEGIC INITIATIVES
9.12.4. SCOT ANALYSIS
9.12.5. STRATEGIC ANALYSIS
9.13. PFIZER(US)
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. STRATEGIC INITIATIVES
9.13.4. SCOT ANALYSIS
9.13.5. STRATEGIC ANALYSIS
9.14. ROCHE(SWITZERLAND)
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. STRATEGIC INITIATIVES
9.14.4. SCOT ANALYSIS
9.14.5. STRATEGIC ANALYSIS
9.15. SAS INSTITUTE, INC.(US)
9.15.1. OVERVIEW
9.15.2. PRODUCT PORTFOLIO
9.15.3. STRATEGIC INITIATIVES
9.15.4. SCOT ANALYSIS
9.15.5. STRATEGIC ANALYSIS
LIST OF TABLES
1. GLOBAL ANESTHESIA DRUGMARKET BY TYPE 2015-2024 ($ MILLION)
2. GLOBAL GENERAL ANESTHESIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
3. GLOBAL SPINAL ANESTHESIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
4. GLOBAL PERIPHERAL NERVE BLOCK MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
5. GLOBAL SADDLE BLOCK ANESTHESIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
6. GLOBAL INTERSCALENE BLOCK MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
7. GLOBAL IV REGIONAL ANESTHESIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
8. GLOBAL ANESTHESIA DRUGMARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
9. GLOBAL INJECTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
10. GLOBAL INHALATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
11. GLOBAL ANESTHESIA DRUGMARKET BY PRODUCT 2015-2024 ($ MILLION)
12. GLOBAL PROPOFOL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
13. GLOBAL SEVOFLURANE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
14. GLOBAL DESFLURANE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
15. GLOBAL REMIFENTANIL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
16. GLOBAL MIDAZOLAM MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
17. GLOBAL DEXMEDETOMIDINE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
18. GLOBAL OTHERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
19. NORTH AMERICA ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
20. EUROPE ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
21. ASIA PACIFIC ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
22. REST OF THE WORLD ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
23. NORTH AMERICA ANESTHESIA DRUGMARKET BY TYPE 2015-2024 ($ MILLION)
24. EUROPE ANESTHESIA DRUGMARKET BY TYPE 2015-2024 ($ MILLION)
25. ASIA PACIFIC ANESTHESIA DRUGMARKET BY TYPE 2015-2024 ($ MILLION)
26. REST OF THE WORLD ANESTHESIA DRUGMARKET BY TYPE 2015-2024 ($ MILLION)
27. NORTH AMERICA ANESTHESIA DRUG MARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
28. EUROPE ANESTHESIA DRUGMARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
29. ASIA PACIFIC ANESTHESIA DRUG MARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
30. REST OF THE WORLD ANESTHESIA DRUG MARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
31. NORTH AMERICA ANESTHESIA DRUGMARKET BY PRODUCT 2015-2024 ($ MILLION)
32. EUROPE ANESTHESIA DRUGMARKET BY PRODUCT 2015-2024 ($ MILLION)
33. ASIA PACIFIC ANESTHESIA DRUGMARKET BY PRODUCT 2015-2024 ($ MILLION)
34. REST OF THE WORLD ANESTHESIA DRUGMARKET BY PRODUCT 2015-2024 ($ MILLION)
35. UNITED STATES ANESTHESIA DRUG MARKET BY TYPE 2015-2024 ($ MILLION)
36. UNITED STATES ANESTHESIA DRUG MARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
37. UNITED STATES ANESTHESIA DRUG MARKET BY PRODUCT 2015-2024 ($ MILLION)
38. CANADA ANESTHESIA DRUG MARKET BY TYPE 2015-2024 ($ MILLION)
39. CANADA ANESTHESIA DRUG MARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
40. CANADA ANESTHESIA DRUG MARKET BY PRODUCT 2015-2024 ($ MILLION)
41. UK ANESTHESIA DRUG MARKET BY TYPE 2015-2024 ($ MILLION)
42. UK ANESTHESIA DRUG MARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
43. UK ANESTHESIA DRUG MARKET BY PRODUCT 2015-2024 ($ MILLION)
44. FRANCE ANESTHESIA DRUG MARKET BY TYPE 2015-2024 ($ MILLION)
45. FRANCE ANESTHESIA DRUG MARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
46. FRANCE ANESTHESIA DRUG MARKET BY PRODUCT 2015-2024 ($ MILLION)
47. GERMANY ANESTHESIA DRUG MARKET BY TYPE 2015-2024 ($ MILLION)
48. GERMANY ANESTHESIA DRUG MARKET BY ROUTES OF ADMINISTRATION 2015-2024 ($ MILLION)
49. GERMANY ANESTHESIA DRUG MARKET BY PRODUCT 2015-2024 ($ MILLION)
50. SPAIN ANESTHESIA DRUG MARKET BY TYPE 2015-2024 ($ MILLION)
LIST OF FIGURES
1. GLOBAL GENERAL ANESTHESIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
2. GLOBAL SPINAL ANESTHESIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
3. GLOBAL PERIPHERAL NERVE BLOCK MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
4. GLOBAL SADDLE BLOCK ANESTHESIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
5. GLOBAL INTERSCALENE BLOCK MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
6. GLOBAL IV REGIONAL ANESTHESIA MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
7. GLOBAL INJECTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
8. GLOBAL INHALATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
9. GLOBAL PROPOFOL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
10. GLOBAL SEVOFLURANE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
11. GLOBAL DESFLURANE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
12. GLOBAL REMIFENTANIL MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
13. GLOBAL MIDAZOLAM MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
14. GLOBAL DEXMEDETOMIDINE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
15. GLOBAL OTHERS MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)
16. UNITED STATES (U.S.) ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
17. CANADA ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
18. UNITED KINGDOM (UK) ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
19. FRANCE ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
20. GERMANY ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
21. SPAIN ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
22. ROE ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
23. CHINA ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
24. INDIA ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
25. JAPAN ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
26. AUSTRALIA ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
27. ROAPAC ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
28. LATIN AMERICA ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)
29. MENA ANESTHESIA DRUGMARKET 2015-2024 ($ MILLION)